Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by Magnum2on May 03, 2020 1:43pm
190 Views
Post# 30981216

After reading thru the details on Mesoblast's NR

After reading thru the details on Mesoblast's NRI clearly see why Lattice/Guy have their hands full to releasing a proper NR.

LBL, has to discuss the findings, have all the agencies involved, ie. FDA, perhaps CDC, local, State Gov'ts, National Gov'ts, hospitals/clinics.

Then from the findings they have to discuss the next step to advance LBL's trial process...this could be another round, to a gammit of outcomes.

Funding, Mesoblast has pre-sold royalties, while I do not understand on what at this point, I fully expect if LBL/Lattice can move this forward that many other possible areas of funding/grants etc. from Gov'ts etc. will be available to them.  

The Govenor Cuomo, New York State conference almost an hour on CNN this morning clearly illustraits the need and desire for the U.S. to have an at home push for PPE, testing, reagents, sanitizer, and cures, etc. accessible within in the U.S. to avoid being left out again.  The U.S. and Trump now more than ever are big supporters of Made in the USA, funding should ramp up to support U.S solutions.

Alot to consider, but the opportunity has opened up greatly to support Lattice IMO.

GLTA
<< Previous
Bullboard Posts
Next >>